Mysterious Tampa biotech startup raises $7 million
January 14, 2021 - InflammX Therapeutics Inc., a Tampa-based biotech company founded last year, has raised more than $7 million from investors, according to a Jan. 13 Form D filing with the U.S. Securities and Exchange Commission. The company does not have a website but its address is listed as 275 Bayshore Blvd., Unit 1607, Tampa. Brian Levy (president and CEO) of Tampa and David Pool (CFO) of San Diego are identified as its executive officers in the SEC filing. A call to the company phone number listed in the filing would not go through.